Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly Orgel

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|June 30, 2018
A Mouse Model of Peanut Allergy Induced by Sensitization Through the Gastrointestinal TractKelly Orgel, Michael Kulis
Current Allergy and Asthma Reports|April 4, 2016
Peanut Allergy: New Developments and Clinical ImplicationsScott P Commins, Edwin H Kim, Kelly Orgel, et al.
Pediatrics|October 24, 2023
Early Peanut Introduction in Infants: Improving Guideline Adherence With EMR StandardizationLauren E Herlihy, Elizabeth M Walters, Jennifer P D'Auria, et al.
Gut Microbes|July 27, 2016
Intestinal bacteria are necessary for doxorubicin-induced intestinal damage but not for doxorubicin-induced apoptosisRachael J Rigby, Jacquelyn Carr, Kelly Orgel, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 2, 2018
Blocking antibodies induced by peanut oral and sublingual immunotherapy suppress basophil activation and are associated with sustained unresponsivenessKelly Orgel, Caitlin Burk, Johanna Smeekens, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 31, 2017
Preparation and Analysis of Peanut Flour Used in Oral Immunotherapy Clinical TrialsJelena P Berglund, Nicole Szczepanski, Anusha Penumarti, et al.
Journal of Human Genetics|December 2, 2017
Characterization of the B-cell receptor repertoires in peanut allergic subjects undergoing oral immunotherapyKazuma Kiyotani, Tu H Mai, Rui Yamaguchi, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 21, 2018
High- and low-dose oral immunotherapy similarly suppress pro-allergic cytokines and basophil activation in young childrenMichael Kulis, Xiaohong Yue, Rishu Guo, et al.
The Journal of Allergy and Clinical Immunology|October 22, 2018
Genetic diversity between mouse strains allows identification of the CC027/GeniUnc strain as an orally reactive model of peanut allergyKelly Orgel, Johanna M Smeekens, Ping Ye, et al.
The Journal of Allergy and Clinical Immunology|April 26, 2024
A mutation in Themis contributes to anaphylaxis severity following oral peanut challenge in CC027 miceEllen L Risemberg, Johanna M Smeekens, Marta C Cruz Cisneros, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|June 30, 2018
A Mouse Model of Peanut Allergy Induced by Sensitization Through the Gastrointestinal TractKelly Orgel, Michael Kulis
Current Allergy and Asthma Reports|April 4, 2016
Peanut Allergy: New Developments and Clinical ImplicationsScott P Commins, Edwin H Kim, Kelly Orgel, et al.
Pediatrics|October 24, 2023
Early Peanut Introduction in Infants: Improving Guideline Adherence With EMR StandardizationLauren E Herlihy, Elizabeth M Walters, Jennifer P D'Auria, et al.
Gut Microbes|July 27, 2016
Intestinal bacteria are necessary for doxorubicin-induced intestinal damage but not for doxorubicin-induced apoptosisRachael J Rigby, Jacquelyn Carr, Kelly Orgel, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 2, 2018
Blocking antibodies induced by peanut oral and sublingual immunotherapy suppress basophil activation and are associated with sustained unresponsivenessKelly Orgel, Caitlin Burk, Johanna Smeekens, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 31, 2017
Preparation and Analysis of Peanut Flour Used in Oral Immunotherapy Clinical TrialsJelena P Berglund, Nicole Szczepanski, Anusha Penumarti, et al.
Journal of Human Genetics|December 2, 2017
Characterization of the B-cell receptor repertoires in peanut allergic subjects undergoing oral immunotherapyKazuma Kiyotani, Tu H Mai, Rui Yamaguchi, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 21, 2018
High- and low-dose oral immunotherapy similarly suppress pro-allergic cytokines and basophil activation in young childrenMichael Kulis, Xiaohong Yue, Rishu Guo, et al.
The Journal of Allergy and Clinical Immunology|October 22, 2018
Genetic diversity between mouse strains allows identification of the CC027/GeniUnc strain as an orally reactive model of peanut allergyKelly Orgel, Johanna M Smeekens, Ping Ye, et al.
The Journal of Allergy and Clinical Immunology|April 26, 2024
A mutation in Themis contributes to anaphylaxis severity following oral peanut challenge in CC027 miceEllen L Risemberg, Johanna M Smeekens, Marta C Cruz Cisneros, et al.
Pageof 2